338 related articles for article (PubMed ID: 9171354)
1. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
2. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
[TBL] [Abstract][Full Text] [Related]
3. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
[TBL] [Abstract][Full Text] [Related]
4. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
5. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
[TBL] [Abstract][Full Text] [Related]
6. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
[TBL] [Abstract][Full Text] [Related]
7. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
8. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
[TBL] [Abstract][Full Text] [Related]
9. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
10. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
11. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
12. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
13. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
Hofmann TJ; Cole MD
Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
[TBL] [Abstract][Full Text] [Related]
14. SCL and related hemopoietic helix-loop-helix transcription factors.
Green AR; Begley CG
Int J Cell Cloning; 1992 Sep; 10(5):269-76. PubMed ID: 1453013
[TBL] [Abstract][Full Text] [Related]
15. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract][Full Text] [Related]
16. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
17. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
Shivdasani RA; Mayer EL; Orkin SH
Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
[TBL] [Abstract][Full Text] [Related]
18. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia.
Elwood NJ; Begley CG
Cell Growth Differ; 1995 Jan; 6(1):19-25. PubMed ID: 7718483
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
Raghavan SC; Kirsch IR; Lieber MR
J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
